Post-traumatic stress disorder and serotonin: New directions for research and treatment

Journal of Psychiatry and Neuroscience

Volumn 22, Issue 5, 1997, Pages 318-326

  Davis, Lori L ^a,c   Suris, Alina ^b   Lambert, Michael T ^b   Heimberg, Carolyn ^b   Petty, Frederick ^b  

^a UNIVERSITY OF ALABAMA   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; CLOMIPRAMINE; FLUOXETINE; PLACEBO; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

AGGRESSION; ANTISOCIAL BEHAVIOR; BLOOD PRESSURE; BORDERLINE STATE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; NEUROTRANSMISSION; PATHOPHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; RANDOMIZED CONTROLLED TRIAL; REVIEW; SEROTONINERGIC SYSTEM; TREATMENT OUTCOME;

HUMANS; SEROTONIN; STRESS DISORDERS, POST-TRAUMATIC;

EID: 0031457755     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Kessler RC, Sonnega A, Bromet E, Hughes M, Nelson CB. Posttraumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry 1995;52:1048-60.
2. Kulka RL, Schlenger WE, Fairbank JA, et al. The National Vietnam Veterans Readjustment Study - tables of findings and technical appendices. New York: Brunner/Mazel Publishers; 1990.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th rev ed. Washington: The Association; 1994.
4. Lambert MT, Hendrickse W, Andrews R, Zelanko J, Fowler DR. Malignant post-Vietnam stress syndrome revisited. J Nerv Ment Dis 1996;184:354-7.
5. Grillon C, Southwick SM, Charney DS. The psychobiological basis of posttraumatic stress disorder. Mol Psychiatr 1996;1:278-97.
6. Charney DS, Deutch AY, Krystal JH, Southwick SM, Davis M. Psychobiologic mechanisms of posttraumatic stress disorder. Arch Gen Psychiatry 1993;50:294-306.
7. Southwick SM, Bremner D, Krystal JH, Charney DS. Psychobiologic research in post-traumatic stress disorder. Psychiatr Clin North Am 1994;17:251-64.
8. Southwick SM, Yehuda R, Morgan CA. Clinical studies of neurotransmitter alterations in post-traumatic stress disorder. In: Friedman MJ, Charney DS, Deutch AJ, editors. Neurobiological and clinical consequences of stress. Philadelphia: Lippincott-Raven; 1995. p. 335-49.
9. Sutherland SM, Davidson RT. Pharmacotherapy for post-traumatic stress disorder. Psychiatr Clin North Am 1994;17:409-23.
10. Dubovsky SL. Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents [review]. J Clin Psychiatry 1994;55(suppl):34-44.
11. Graeff FG, Guimaraes FS, Deandrade TGCS, Deakin JFW. Role of 5-HT in stress, anxiety, and depression [review]. Pharmacol Biochem Behav 1996;54:129-41.
12. Goddard AW, Woods SW, Charney DS. A critical review of the role of norepinephrine in panic disorder: focus on its interaction with serotonin. In: Westenberg HGM, Boer AD, Murphy DL, editors. Advances in the neurobiology of anxiety disorders. New York: John Wiley and Sons; 1996. p. 107-37.
13. Bremner JD, Randall P, Vermetten E, Staib L, Bronen RZ, Mazure C, et al. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse - a preliminary report. Biol Psychiatry 1997;41:23-32.
14. Bremner JD, Randall P, Scott T, Bronen RA, Seibyl JP, Southwick SM, et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry 1995;152(7):973-81.
15. Bremner JD, Innis RB, Ng CK, Staib LH, Salomon RM, Bronen RA. Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Arch Gen Psychiatry 1997;54:246-54.
16. Shin LM, Kosslyn SM, McNally RJ, Alpert NM, Thompson WL, Rauch SL, Macklin ML, Pitman RK (1997) Visual imagery and perception in posttraumatic stress disorder: a positron emission tomographic investigation. Arch Gen Psychiatry 54:233-241
17. Mann JJ, Malone KM, Diehl DJ, Perel J, Cooper TB, Mintun MA. Demonstration in vivo of reduced serotonin responsivity in the brain of untreated depressed patients. Am J Psychiatry 1996;153(2):174-82.
18. Orsillo SM, Weathers FW, Litz BT, Steinberg BA, Huska JA, Keane TM. Current and lifetime psychiatric disorders among veterans with war zone-related posttraumatic stress disorder. J Nerv Ment Dis 1996;184:307-13.
19. Maes M, Meltzer HY. The serotonin hypothesis of depression. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology - fourth generation in progress. New York: Raven Press; 1995. p. 933-44.
20. O'Keane V, Moloney E, O'Neill H, O'Conner A, Smith C, Dinan TG. Blunted prolactin responses to d-fenfluramine in sociopathy: evidence for subsensitivity of central serotonergic function. Br J Psychiatry 1992;160:643-6.
21. Coccaro EF, Siever LJ, Kavoussi R, Davis KL. Impulsive aggression in personality disorder: evidence for involvement of 5-HT receptors. Biol Psychiatry 1989;25:86.
22. Southwick SM, Yehuda R, Giller EL, Charney DS. Personality disorders in treatment-seeking combat veterans with posttraumatic stress disorder. Am J Psychiatry 1993;150(7):1020-3.
23. Blank AS. Clinical detection, diagnosis, and differential diagnosis of post-traumatic stress disorder. Psychiatr Clin North Am 1994;17:351-83.
24. Lasko NB, Gurvits TV, Kuhne AA, Orr SP, Pitman RK. Aggression and its correlates in Vietnam veterans with and without chronic posttraumatic stress disorder. Comp Psychol 1994;35:373-81.
25. Hiley-Young B , Blake DD , Abueg FR , Gusman FD. Warzone violence in Vietman: an examination of premilitary, military, and postmilitary factors in PTSD in-patients. J Trauma Stress 1995;8:125-40.
26. Higley JD, King ST, Hasert MF, Champoux M, Suomi SJ, Linnoila M. Stability of interindividual differences in serotonin function and its relationship to severe aggression and competent social behavior in rhesus macaque females. Neuropsychopharmacology 1996;14:67-76.
27. Copenhaver JH, Schalock RL, Johnson L, Stull T, Pankratz T. Relationship between preexposure to prey and PCPA-induced filicidal activity in Sprague-Dawley rats. Physiol Behav 1989;45:343-6.
28. Verges M, Depaulis A, Boehrer A, Kempf E. Selective increase of offensive behavior in the rat following intrahypothalamic 5,7-DHT-induced serotonin depletion. Behav Brain Res 1988;29:85-91.
29. Manev H, Pericic D, Muck-Seler D. Inhibitory influence of dehydroergosine on the aggressiveness of rats and mice. Pharmacol Biochem Behav 1989;32:111-5.
30. Brown GL, Linnoila MI. CSF serotonin metabolite (5-HIAA) studies in depression, impulsivity, and violence. J Clin Psychiatry 1990;51(suppl 4):31-41.
31. Linnoila M, Virkkunen M. Aggression, suicidality, and serotonin. J Clin Psychiatry 1992;53 (suppl):46-51.
32. Mann JJ. Violence and aggression. In: Bloom FE, Kupfer DJ, editors. Psychopharmacology - fourth generation in progress. New York: Raven Press; 1995. p. 1919-28.
33. Davis LL, Kramer GL, Rush AJ, et al. Biological trait markers of depression. In: Panksepp J, editor. Advances in biological psychiatry, vol 2. Greenwich (CT): JAI Press; 1996. p. 115-51.
34. Moeller FG, Dougherty DM, Swann AC, Collins D, Davis CM, Cherek DR. Tryptophan depletion and aggressive responding in healthy males. Psychopharmacology 1996;126:97-103.
35. Handelsman L, Holloway K, Kahn RS, Sturiano C, Rinaldi PJ, Bernstein DP, et al. Hostility is associated with a low prolactin response to meta-chlorophenylpiperazine in abstinent alcoholics. Alcohol Clin Exp Res 1996;20:824-9.
36. Arora RC, Fichtner CG, O'Connor F, Crayton JW. Paroxetine binding in the blood platelets of post-traumatic stress disorder patients. Life Sci 1993;53:919-28.
37. Fichtner CG, O'Connor FL, Yeoh HC, Arora RC, Crayton JW. Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features. Life Sci 1995;57:PL37-44.
38. Fichtner CG, Arora RC, O'Connor FL, Crayton JW. Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder - preliminary observations on a possible predictor of clinical treatment response. Life Sci 1994;54:PL39-44.
39. Mellman TA, Kumar AM. Platelet serotonin measures in posttraumatic stress disorder. Psychiatry Res 1994;53:99-101.
40. Shalev AY, Bonne O, Eth S. Treatment of posttraumatic stress disorder: a review. Psychosoin Med 1996;58:165-82.
41. Friedman MJ, Southwick SM. Towards pharmacotherapy for post-traumatic stress disorder. In: Friedman MJ, Charney DS, Deutch AY, editors. Neurobiological and clinical consequences of stress. Philadelphia: Lippincott-Raven; 1995. p. 465-81.
42. Solomon SD, Gerrity ET, Muff AM. Efficacy of treatments for posttraumatic stress disorder. JAMA 1992;268(5):633-8.
43. van der Kolk BA, Dreyfuss D, Michaels M, Shera D, Berkowitz R, Fisler R, et al. Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 1994;55(12):517-22.
44. McDougle CJ, Southwick SM, Charney DS, St. James RL. An open trial of fluoxetine in the treatment of posttraumatic stress disorder. J Clin Psychopharmacol 1991;11:325.
45. Nagy LM, Morgan CA, Southwick SM, Charney DS. Open prospective trial of fluoxetine for posttraumatic stress disorder. J Clin Psychopharmacol 1993;13:107-13.
46. March JS. Fluoxetine and fluvoxamine in PTSD. Am J Psychiatry 1992;149(3):413.
47. Shay J. Fluoxetine reduces explosiveness and elevates mood of Vietnam combat vets with PTSD. J Trauma Stress 1992;5:97-101.
48. Davidson JRT, Roth S, Newman E. Fluoxetine in posttraumatic stress disorder. J Trauma Stress 1991;4:419-23.
49. Marmar CR, Schoenfeld F, Weiss DS, Metzler T, Zatzick D, Wu R, et al. Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder. J Clin Psychiatry 1996;57(suppl):66-72.
50. De Boer M, Op den Velde W, Falger P, Hovens JE, De Groen J, van Duijn H. Fluvoxamine treatment for chronic PTSD: a pilot study. Psychother Psychosom 1992;57:158-63.
51. Kline NA, Dow BM, Brown SA, Matloff JL. Sertraline efficacy in depressed combat veterans with posttraumatic stress disorder [abstract no. NR641]. In: Proceedings and abstracts of the 146th Annual Meeting of the American Psychiatric Association 146th Meeting; San Francisco, 1993.
52. Brady KT, Sonne SC, Roberts JM. Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. J Clin Psychiatry 1995;56:502-5.
53. Rothbaum BO, Ninan PT, Thomas L. Sertraline in the treatment of rape victims with posttraumatic stress disorder. J Trauma Stress 1996;9:865-71.
54. Chen C-J. The obsessive quality and clomipramine treatment in PTSD. Am J Psychiatry 1991;148:1087-8.
55. Duffy JD, Malloy PF. Efficacy of buspirone in the treatment of posttraumatic stress disorder: an open trial. Ann Clin Psychiatry 1994;6:33-7.
56. LaPorta LD, Ware MR. Buspirone in the treatment of posttraumatic stress disorder. J Clin Psychopharmacol 1992;12:133-4.
57. Wells GB, Chu C, Johnson R, Nasdahl C, Ayubi MA, Sewell E, et al. Buspirone in the treatment of posttraumatic stress disorder. Pharmacotherapy 1991;11:340-3.